High frequency of mononuclear myeloid-derived suppressor cells is associated with exacerbation of inflammatory bowel disease

Immunological Investigations

Volumn 44, Issue 3, 2015, Pages 279-287

  Xi, Qinhua ^a   Li, Yueqin ^a   Dai, Juan ^a   Chen, Weichang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Exacerbation; IBD; MDSC; Remission

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EXPERIMENTAL COLITIS; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; REMISSION; SUPPRESSOR CELL; ULCERATIVE COLITIS; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; CHEMICALLY INDUCED; COLITIS; DISEASE COURSE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MONONUCLEAR CELL; MUCOSAL IMMUNITY;

DEXTRAN SULFATE;

ADULT; ANIMALS; COLITIS; DEXTRAN SULFATE; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOSUPPRESSION; INFLAMMATORY BOWEL DISEASES; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MYELOID CELLS;

EID: 84928016307     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2014.999937     Document Type: Article

References (26)

1. Braat H, Peppelenbosch MP, Hommes DW. (2006). Immunology of Crohn's disease. Ann N Y Acad Sci, 107, 135-54.
2. Chalmin F, Ladoire S, Mignot G, et al. (2010). Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest, 120, 457-71.
3. Dauphinee SM, Karsan A. (2006). Lipopolysaccharide signaling in endothelial cells. 2006. Lab Invest, 86, 9-22.
4. Delano MJ, Scumpia PO, Weinstein JS. (2007). MyD88-dependent expansion of an immature GR-1 + CD11b population induces T cell suppression and Th2 polarization in sepsis. J Exp Med, 204, 1463-74.
5. Dharmani P, Chadee K. (2008). Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol, 1, 195-212.
6. Diaz-Montero CM, Finke J, Montero AJ. (2014). Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications. Semin Oncol, 41, 174-84.
7. Dieleman LA, Palmen MJ, Akol H, et al. (1998). Chronic experimental colitis induced by dextran sulphate sodium(DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol, 114, 385-91.
8. Filipazzi P, Valenti R, Huber V, et al. (2007). Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol, 25, 2546-53.
9. Fujimura T, Mahnke K, Enk AH. (2010). Myeloid derived suppressor cells and their role in tolerance induction in cancer. J Dermatol Sci, 59, 1-6.
10. Fujimura T, Ring S, Umansky V, et al. (2012). Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas. Invest Dermatol, 132, 1239-46.
11. Fujita M, Kohanbash G, Fellows-Mayle W, et al. (2011). COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res, 71, 2664-74.
12. Gabrilovich DI, Nagaraj S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 9, 162-74.
13. Haile LA, von Wasielewski R, Gamrekelashvili J, et al. (2008). Myeloid-derived suppressor cells in inflammatory bowel disease: A new immunoregulatory pathway. Gastroenterology, 135, 871-81.
14. Hoechst B, Ormandy LA, Ballmaier M, et al. (2008). A new population of myeloidderived suppressor cells in hepatocellular carcinoma patients induces CD4 + CD25 + Foxp3 + T cells. Gastroenterology, 135, 234-43.
15. Kaser A, Zeissig S, Blumberg RS. (2010). Inflammatory bowel disease. Annu Rev Immunol, 28, 573-621.
16. Lin Y, Gustafson MP, Bulur PA, et al. (2011). Immunosuppressive CD14+HLA-DR(low)/-monocytes in B-cell non-Hodgkin lymphoma. 2011. Blood, 117, 872-81.
17. Mundy-Bosse BL, Lesinski GB, Jaime-Ramirez AC, et al. (2011). Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res, 71, 5101-10.
18. Obermajer N, Muthuswamy R, Odunsi K, et al. (2011). PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res, 71, 7463-70.
19. Pan PY, Ma G, Weber KJ, et al. (2010). Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res, 70, 99-108.
20. Poschke I, Mougiakakos D, Hansson J, et al. (2010). Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res, 70, 4335-45.
21. Ren WH, Lai M, Chen Y, et al. (2007). Validation of the mainland Chinese version of the inflammatory bowel disease questionnaire (IBDQ) for ulcerative colitis and Crohn's disease. Inflam Bowel Dis, 13, 903-10.
22. Sekine Y, Yumioka T, Yamamoto T, et al. (2006). Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages. J Immunol, 176, 380-9.
23. Vuk-Pavlovic S, Bulur PA, Lin Y, et al. (2010). Immunosuppressive CD14+HLA-DRlow/-monocytes in prostate cancer. Prostate, 70, 443-55.
24. Wendelsdorf K, Bassaganva-Riera J, Hontecillas R, Eubank S. (2010). Modle of colonic inflammation: immune modulatory mechanism in inflammatory bowel disease. 2010. J Theor Boil, 264, 1225-39.
25. Xavier RJ, Podolsky DK. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature, 448, 427-34.
26. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. (2008). Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol, 181, 5791-802.